Jeff Bridges Says COVID Made Cancer'Look Like A Piece of Cake'Jeff Bridges Says COVID Made Cancer'Look Like A Piece of Cake '

Actor Jeff Bridges, 71, said Monday that his lymphoma is in remission and that he is feeling better after contracting COVID-19. He was hospitalized for 5 weeks.WebMD Health News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

Related Links:

Clin J Oncol Nurs. 2021 Oct 1;25(5):608. doi: 10.1188/21.CJON.608.ABSTRACTMy passion for oncology started when I was just eight years old. My mother sat with me and shared that my dad had cancer. I saw my father cry as I heard the news, so I immediately knew something was very, very wrong. My father was diagnosed with mantle cell lymphoma and was given only six months to live. He fought for five long years and left a legacy of love, laughter, and Kenny Chesney sing-alongs. Fast-forward 15 years, and I landed my first nursing job on an oncology unit. My dream of working with patients with cancer was finally coming true, or ...
Source: Clinical Journal of Oncology Nursing - Category: Nursing Authors: Source Type: research
In this study, mature DCs (mDCs), generated from the GM-CSF and IL-4 induced bone marrow cells, were intravenously injected into wild-type mice. Three days later, assays showed that the mDCs were indeed able to return to the thymus. Homing DCs have been mainly reported to deplete thymocytes and induce tolerance. However, medullary TECs (mTECs) play a crucial role in inducing immune tolerance. Thus, we evaluated whether the mDCs homing into the thymus led to TECs depletion. We cocultured mDCs with mTEC1 cells and found that the mDCs induced the apoptosis and inhibited the proliferation of mTEC1 cells. These effects were onl...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Dr. David Prezant was knocked fully airborne at 9:59 on the morning of Sept. 11, 2001. He didn’t see the impact coming, but he felt it when it hit—and it nearly killed him. Little more than an hour earlier, Prezant, then the deputy chief medical officer of the Fire Department of New York, was headed for his usual workplace at the FDNY’s Office of Medical Affairs, just across the Manhattan Bridge in Brooklyn. He had already heard that a plane had hit the North Tower of the World Trade Center, and he reckoned that it was an accident. By the time he reached his office, however, the South Tower had been struc...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthscienceclimate Source Type: news
In conclusion, patients with CLL/lymphomas have low humoral response following COVID-19 vaccination, underlining the need for timely vaccination ideally during a treatment-free period and for continuous vigilance on infection control measures.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
CONCLUSION: Most pediatric cancer patients with COVID-19 should have good clinical outcomes except for patients with critical infections. Cancer patients can tolerate chemotherapy including induction phase, alongside COVID-19 treatment. In severe and critical COVID-19, RDV might have a potential benefit.PMID:34420893 | PMC:PMC8312090 | DOI:10.1016/j.clml.2021.07.025
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research
Conditions:   COVID-19 Infection;   Hematopoietic and Lymphoid System Neoplasm;   Leukemia;   Lymphoma;   Plasma Cell Myeloma Interventions:   Biological: COVID-19 Vaccine;   Other: Diagnostic Laboratory Biomarker Analysis;   Biological: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Few cancer centers from developing countries have described the impact of COVID-19 on pediatric cancer patients. Seventy-six pediatric oncology patients with COVID-19 infection were recruited. Most patients had a favourable outcome with sixty-day overall survival of 86.8%. Mortalities occurred only among patients with critical forms of infection. The potential benefits  of remdesivir in pediatric oncology patients require further studies.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research
SARS-CoV-2 (COVID-19) infection has a negative impact on the outcomes of patients with cancer, with mortality rates over 20%.1-3 This is especially important in adults with hematologic neoplasias and in those submitted to allogeneic hematopoietic stem cell transplant (HSCT), in whom the death rate is over 30%4-8 compared to 4% in children.4 Patients with active disease and those receiving intensive chemotherapy or immunotherapy are especially vulnerable. Apart from the cancer itself other factors such as advanced age, poor general status and neutropenia contribute to this high mortality rate.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research
CONCLUSION: Cancer out-patients of the present sample have severe post-traumatic stress symptoms and psychological distress, those with lung cancer are at higher risk and may need special attention. Non-oncological subjects have higher depression levels than cancer patients.PMID:34268981
Source: Journal of B.U.ON. - Category: Cancer & Oncology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Health | Hematology | Infectious Diseases | Lymphoma